16
Dec
Tujoromajo Kasuto All vaccination centres have commenced with the voluntary administration of 3rd dose/booster of Sinopharm, AstraZeneca and Pfizer BioNTech vaccines to eligible individuals. The same type of vaccine should be used in the primary/initial series. However, if the same product is not available, or in case of an allergic reaction to one vaccine, another COVID-19 vaccine can be administered. Executive Director (ED) in the Ministry of Health and Social Services (MoHSS), Ben Nangombe, says research has been conducted on the safety and effectiveness of mix-and-matching of COVID-19 vaccines. Findings have shown that persons who receive two different COVID-19 vaccines…